Relevant bibliographies by topics / Female sexual dysfunctions

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers

Academic literature on the topic 'Female sexual dysfunctions'

Author: Grafiati
Published: 4 June 2021
Last updated: 2 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Female sexual dysfunctions.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Female sexual dysfunctions"

1

Rao, T. S. Sathyanarayana. "Female Sexual Dysfunctions." Indian Journal of Psychological Medicine 27, no. 1 (July 2005): 129–53. http://dx.doi.org/10.1177/0975156420050114.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Sheahan, Sharon L. "Identifying Female Sexual Dysfunctions." Nurse Practitioner 14, no. 2 (February 1989): 25???35. http://dx.doi.org/10.1097/00006205-198902000-00006.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Stenyaeva, Natalia N., Dmitrii F. Chritinin, and Andrei A. Chausov. "Gynecological diseases as predictors of female sexual dysfunction." Gynecology 23, no. 2 (May 27, 2021): 149–54. http://dx.doi.org/10.26442/20795696.2021.2.200784.

Full text
Abstract:
Background. Female sexual dysfunction is extremely common and affects about half of the worlds women. Currently, the question of the relationship between gynecological morbidity in women and the characteristics of sexual activity and sexual functioning in a couple remains poorly understood. Aim. To establish gynecological diseases associated with decreased sexual functioning, sexual health disorders in women on the basis of a screening assessment when visiting the clinic. Materials and methods. We conducted a cross-sectional descriptive study of the sexual functioning of 1256 women who presented to outpatient appointments. Anamnestic and clinical methods were used, sexological testing using the Female Sexual Function Index questionnaire. Results. Based on anamnestic data, screening assessment of sexual health and sexual functioning of 1235 women who applied for outpatient appointments to a gynecological clinic, a high gynecological and extragenital morbidity was established in patients (100%). The structure of gynecological diseases is represented by female infertility (48.3%), inflammatory diseases of the genital organs (38.5%; of which salpingo-oophoritis 16.6% and vulvovaginitis 15.9%), endometriosis (13.9%) , menstrual irregularities (8.3%), as well as pain disorders (8.1%). The incidence of infections, predominantly sexually transmitted, was revealed, among them papillomatous viral infection (8.3%), genital herpes (5.3%) and chlamydia (3.7%). It was found that in gynecological patients with diseases characterized by a chronic course, inflammation, pelvic pain, menstrual and reproductive disorders, sexual functioning significantly decreases (p=0.00) and sexual health is impaired. Sexual dysfunctions were detected in 21.6% of patients, their structure is represented by isolated (39.3%) and combined (60.7%) disorders of libido, orgasm, sexual anhedonia, failure of genital response, as well as dyspareunia, vaginismus. In 33.7% of patients, preclinical forms of sexual dysfunction were identified that did not meet the criteria for sexual dysfunction (did not cause distress, were short-lived), but confirmed by the analysis of patient complaints, as well as by the results of the Female Sexual Function Index questionnaire. Conclusion. Thus, chronic gynecological diseases with inflammatory manifestations, pelvic pain, menstrual and reproductive dysfunctions are associated with decreased sexual functioning, sexual dysfunctions, and preclinical forms of sexual dysfunctions.
APA, Harvard, Vancouver, ISO, and other styles
4

Clayton, Anita H. "Female Sexual Dysfunctions: What Controversy?" Journal of Clinical Psychiatry 67, no. 06 (June 15, 2006): 991–92. http://dx.doi.org/10.4088/jcp.v67n0617.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

DeRogatis, Leonard R., Jeffrey Edelson, Robert Jordan, Sally Greenberg, and David J. Portman. "Bremelanotide for Female Sexual Dysfunctions." Obstetrics & Gynecology 123 (May 2014): 26S. http://dx.doi.org/10.1097/01.aog.0000447289.23270.72.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Rocha, Lorena Calline Brito, Margarany Mascarenhas Mendes, and Aline Moreira Ribeiro. "Beliefs and Sexual Education Influence the Development of Female Sexual Dysfunctions? - A Literature Review." Current Research Journal of Social Sciences and Humanities 2, no. 2 (January 1, 2020): 72–78. http://dx.doi.org/10.12944/crjssh.2.2.01.

Full text
Abstract:
Understanding women in their entirety, considering not only organic aspects but also psychological, sentimental, relational, and beliefs aspects is of paramount importance for the individualized approach to sexual dysfunction. The professional should seek to understand the factors that lead to the development of dysfunctions. Thus, understanding whether sexuality beliefs and education influence sexual dysfunctions may be a differential to treatment success, as well as in the management of attention directed toward women with dysfunction. To identify the influence of beliefs and sexual education for the development of female sexual dysfunctions. We searched publications in the databases SciELO, PubMed and Virtual Health Library covering the following key words: “female sexual dysfunctions”, “beliefs” and “sexual education”. A descriptive analysis of the results was performed in which data presentation followed exclusively the terminologies followed by the authors. Five hundred and fifty-two articles were found. Considering the exclusion criteria, only two articles were selected for review. The sample size was 337 women with a age range of 28.7 to 35 years. The studies were conducted in Portugal and Iran. According to the authors, sexual health education is effective in improving female sexual function, since the belief that sexual desire and pleasure are sinful seems to be related to hypoactive sexual desire. Beliefs about body image may be related to orgasmic disorders in women. The shortage of studies addressing the influence of education and beliefs on female sexual dysfunction demonstrates the importance and necessity of new research using specific markers in order to contribute to a broader and more effective discussion.
APA, Harvard, Vancouver, ISO, and other styles
7

Balon, R. "Diagnosis and Assessment of Female sexual Dysfunction(s)." European Psychiatry 24, S1 (January 2009): 1. http://dx.doi.org/10.1016/s0924-9338(09)70456-0.

Full text
Abstract:
The first challenge in diagnosing female sexual dysfunction(s) originates in our diagnostic system. The traditional model of classifying sexual dysfunction is anchored in the sexual response cycle: desire - arousal - orgasm - resolution. However, as some experts have pointed out, this classification may be problematic in the area of female sexuality. Both the diagnoses of female hypoactive sexual desire disorder (FHSDD) and female arousal disorder (FSAD) probably need to be redefined and refined. Examples include adding the lack of responsive desire to the FHSDD criteria and creating categories of subjective FSAD and genital FSAD.The second challenge in diagnosis female dysfunction is the lack of solid diagnostic instruments, diagnosis-specific laboratory assays and other specific testing. Specific measures of female sexual functioning, such as Female Sexual Functioning Index, Profile of Female Sexual Functioning, Sexual Function Questionnaire, Sexual Desire and Interest Inventory, and Female Sexual Distress Scale were mostly developed as outcome measures. No solid diagnostic instrument for sexual dysfunction exists, not even a version of the Structured Clinical Interview for DSM sexual dysfunctions. The contribution of imaging techniques, such as ultrasonography, magnetic resonance imaging or thermography, to the diagnosis is unclear, and these techniques are far (if ever) from clinical use.Thus, a detailed comprehensive clinical interview combined with physical examination, possibly a gynecological examination, and in some cases laboratory hormonal testing remains the cornerstone of diagnosing and assessing female sexual dysfunctions.
APA, Harvard, Vancouver, ISO, and other styles
8

Carosa, E., A. Sansone, and E. A. Jannini. "MANAGEMENT OF ENDOCRINE DISEASE: Female sexual dysfunction for the endocrinologist." European Journal of Endocrinology 182, no. 6 (June 2020): R101. http://dx.doi.org/10.1530/eje-19-0903.

Full text
Abstract:
Sexual function is an important component of either general health and quality of life in both genders. Many studies have focused on the different risk factors for sexual dysfunctions, proving an association with several medical conditions. Endocrine disorders have been often mentioned in the pathogenesis of female and male sexual dysfunctions; however, particularly in women, sexual function is rarely addressed during clinical, in general, and endocrinological, in particular, consultations. As a thorough diagnosis is required in order to provide an adequately tailored treatment, knowing how each endocrine dysfunction can impair sexual health is of the utmost importance, considering the high prevalence of conditions such as disorders of pituitary, thyroid, adrenal, gonads, as well as metabolic disorders. We performed a thorough review of existing literature on the different mechanisms involved in the pathogenesis of female sexual dysfunctions secondary to endocrine disorders in order to provide an up-to-date reference.
APA, Harvard, Vancouver, ISO, and other styles
9

Lordello, Maria Claudia, Suzane Holzhacker, Lilian Macri, Laise Veloso, Zelia Macedo, Nina Batista, and Ivaldo Silva. "Psychosocial Difficulties and Female Sexual Dysfunctions." Journal of Sexual Medicine 14, no. 5 (May 2017): e337. http://dx.doi.org/10.1016/j.jsxm.2017.04.595.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Mimoun, Sylvain, and Kevan Wylie. "Female sexual dysfunctions: Definitions and classification." Maturitas 63, no. 2 (June 2009): 116–18. http://dx.doi.org/10.1016/j.maturitas.2009.04.003.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Female sexual dysfunctions"

1

Witting, Katarina. "Classification, comorbidity, heredity, and risk factors of female sexual dysfunctions /." Abo, Finland : Abo Akademi University, 2008. http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&doc_number=017633778&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Bedone, Regina Maria Volpato. "Resposta sexual, disfunção sexual e qualidade de vida em mulheres obesas." Universidade de São Paulo, 2014. http://www.teses.usp.br/teses/disponiveis/5/5160/tde-31032014-160420/.

Full text
Abstract:
Introdução: No Brasil, como em outros países, obesidade e disfunção sexual são consideradas problemas de saúde pública pela alta prevalência e por estarem relacionadas com hipertensão arterial, diabetes, doenças cardiovasculares, transtornos depressivos, outras morbidades e prejuízos na qualidade de vida dos indivíduos. Em geral, há poucos estudos sobre resposta sexual, obesidade e qualidade de vida em mulheres, e, na maioria deles, as pesquisas são realizadas com pacientes portadoras de doenças crônicas. Objetivos: Avaliar a resposta sexual, as disfunções sexuais e a qualidade de vida de mulheres obesas sem outras morbidades associadas e com parceiros não portadores de disfunção sexual. Métodos: Foram selecionadas 37 mulheres obesas (IMC = 30-39,9 Kg/m2) sem outras morbidades, com idade acima de 18 anos, não menopausadas, com parceiro funcional e relacionamento estável. Os parceiros foram avaliados pelo questionário QS-M. Considerando critérios para exclusão de doenças, as pacientes foram submetidas aos seguintes exames laboratoriais: glicose, colesterol e frações, triglicérides, TSH, prolactina, testosterona total, SHBG e testosterona livre. Também foram avaliadas por entrevista clínica e, posteriormente, pelos questionários QS-F, IWQOL-Lite, BDI e HAM-A. Resultados: Das 37 pacientes, 4 (10,8%) foram consideradas disfuncionais (QSF 60) e 33 (89,2%) apresentaram desempenho sexual satisfatório (QS-F 60). Dentre as disfunções sexuais, a diminuição do desejo sexual e a disfunção do orgasmo comprometeram 100% das pacientes; a disfunção de excitação 75%, o vaginismo 50% e a dispareunia 25%. Não houve correlação estatisticamente significativa entre o IMC e o QS-F (r=-0,12; p=0,470). O IWQOL-Lite total, com escore máximo de 155 pontos, variou de 31 a 116 pontos, com mediana de 60,0 pontos. Houve correlação estatisticamente significativa entre o QS-F e os domínios do IWQOL-Lite vida sexual, trabalho e o total. Verificou-se correlação estatisticamente significativa entre o IMC e a QV (r=-0,41; p=0,012). Ocorreu correlação negativa e estatisticamente significativa entre o QSF e o BDI (r= -0,37; p= 0,025), e o HAM-A (r=-0,39; p=0,016). Conclusões: Mulheres obesas sem outras morbidades mostraram um desempenho sexual satisfatório, e não houve correlação entre a obesidade e a presença de disfunção sexual. O melhor desempenho sexual foi associado com a melhor qualidade de vida. Quanto mais obesas, pior a qualidade de vida das pacientes. Quanto melhor o desempenho sexual, menor a possibilidade de depressão e ansiedade
Introduction: In Brazil, as in other countries, obesity and sexual dysfunction are considered public health problems because of their high prevalence and association with high blood pressure, diabetes, cardiovascular disease, depressive disorders, other morbidities, and impaired patient quality of life (QoL). In general, there are few studies on sexual response, obesity, and QoL in women, and in most of these studies, assessments are conducted with patients with chronic diseases. Aims: To assess sexual response, sexual dysfunction, and QoL of obese women without other associated morbidities and partners without sexual dysfunction. Methods: We selected 37 non-menopausal, obese women (body mass index [BMI] = 30-39.9 Kg/m2) without comorbidities, aged > 18 years, with functional partners and stable relationship. The partners were assessed by the SQ-M. Considering the disease exclusion criteria, the patients underwent the following laboratory tests: glucose, cholesterol, high-density lipoprotein, triglycerides, thyroid-stimulating hormone, prolactin, total testosterone, sex hormone-binding globulin, and free testosterone. They were also assessed in a clinical interview and subsequently, by the Sexual Quotient-Female Version (SQ-F), Impact of Weight on the Quality of Life (IWQOL)-Lite, Beck Depression Inventory (BDI), and Hamilton Anxiety Rating Scale (HAM-A) questionnaires. Results: Of the 37 patients, 4 (10.8%) were considered to have sexual dysfunction (SQ-F60), and 33 (89.2%) had satisfactory sexual performance (SQ-F60). Among those with sexual dysfunction, all patients experienced decreased sexual desire and orgasm dysfunction, 75% experienced arousal dysfunction, 50 % experienced vaginismus, and 25 % experienced dyspareunia. No statistically significant correlation was noted between BMI and SQF (r= -0.12; p = 0.470). The total IWQOL-Lite, with a maximum score of 155 points, ranged from 31 to 116 points, with a median of 60.0 points. A statistically significant correlation was observed between the sex life, work, and total domains of the SQ-F and IWQOL-Lite questionnaires, and between BMI and QoL (r = -0.41; p = 0.012). A statistically significant negative correlation was noted between the SQ-F and BDI (r = -0.37, p = 0.025) and HAM-A (r = -0.39, p = 0.016) results. Conclusions: Obese women without comorbidities showed satisfactory sexual performance; no correlation was found between obesity and sexual dysfunction. The best sexual performance was associated with a better QoL. Increase in obesity was associated with a deteriorated QoL of patients. Superior sexual performance was found to be associated with a low possibility of depression and anxiety
APA, Harvard, Vancouver, ISO, and other styles
3

Sahay, Rashmi. "Female Sexual Dysfunction in women with Multiple Sclerosis." University of Cincinnati / OhioLINK, 2010. http://rave.ohiolink.edu/etdc/view?acc_num=ucin1276947276.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Faro, Livi Ferreira Testoni de. "As disfunções sexuais femininas no periódico Archives of Sexual Behavior." Universidade do Estado do Rio de Janeiro, 2008. http://www.bdtd.uerj.br/tde_busca/arquivo.php?codArquivo=4439.

Full text
Abstract:
Após o sucesso de vendas do Viagra, medicamento indicado para o tratamento da disfunção erétil, lançado em 1998, houve uma rápida proliferação de artigos, livros e encontros sobre as disfunções sexuais femininas. Desde 2000, um intenso debate sobre o envolvimento da indústria farmacêutica na produção biomédica sobre as disfunções sexuais femininas e a concomitante busca por um medicamento similar ao Viagra destinado às mulheres tem envolvido profissionais de diferentes disciplinas. Esta dissertação teve como objetivo investigar os discursos científicos sobre as disfunções sexuais femininas, através do exame dos artigos publicados no periódico Archives of Sexual Behavior, desde sua fundação, em 1971, até 2007. O periódico foi escolhido por sua legitimidade neste campo de saberes, por abranger um amplo período (36 anos) e seu caráter multidisciplinar. Pretendeu-se investigar quando, como e por quais grupos profissionais as disfunções sexuais femininas foram descritas e abordadas no periódico. No caso das chamadas disfunções sexuais, as descrições científicas, que vêm aumentando significativamente nos últimos anos, dão origem a prescrições de terapias, medicamentos, intervenções cirúrgicas, programas de educação sexual e políticas públicas. Ou seja, subjacente a esse discurso, que afirma ser empírico e imparcial, estão processos que se encontram muito além dos limites de um laboratório ou das atividades de um pesquisador. Buscou-se, assim, pensar a produção científica como produto de articulações e negociações que se desenrolam em esferas diversas, envolvendo processos culturais, sociais, econômicos e também cognitivos ou científicos, em contraposição às concepções que caracterizam a ciência como um projeto que apenas revela verdades. Para tanto, foi apresentado o contexto do surgimento de uma ciência da sexualidade, no decorrer do século XIX e, em seguida, o contexto no qual emergiram os discursos sobre as disfunções sexuais femininas, o que propiciou sua emergência naquele dado momento, o modo como foram definidas e por quem, como se articularam a processos sociais, econômicos e culturais e que transformações sofreram ao longo dos anos.
After the sale success of Viagra, a medicament indicated for the treatment of erectile dysfunction, which was launched in 1998, there was a fast proliferation of articles, books and meetings on female sexual dysfunctions. Since 2000, an intense debate about the involvement of the pharmaceutical industry in the biomedical production related to female sexual dysfunctions and the simultaneous search for a medicament similar to Viagra aimed to women has been involving professional from different areas. The goal of this dissertation was to investigate scientific discourses on female sexual dysfunctions through the analysis of articles published in the periodical Archives of Sexual Behavior, since its foundation in 1971 until 2007. The periodical was chosen due to its legitimacy in this field of knowledge, for covering a vast period (36 years) and for its multidisciplinary nature. The intention was to locate when, how and by which professional groups female sexual dysfunctions were described and dealt with in the periodical. In the case of the so-called sexual dysfunctions, scientific descriptions, which have been significantly increasing in recent years, originate therapeutic prescriptions, medicaments, chirurgical interventions, sexual education programs and public policies. That is, subjacent to this discourse, which poses as empirical and impartial processes were found that reach quite beyond the limits of a lab or the activities of a researcher. Therefore, the aim was to think of the scientific production as a product of articulations and negotiations unfolded in diversified domains and involving cultural, social and economical processes, as well as cognitive and scientific ones, in contrast to the conceptions that characterize science as a project that only brings about the truth. For this, the context in which a science of sexuality emerged throughout the 19th Century was presented, followed by the context in which the discourses on female sexual dysfunctions appeared: what has facilitated their emergence in that given moment, how and by whom were they defined, how were they articulated to social, economical and cultural processes and which transformations they suffered throughout the years.
APA, Harvard, Vancouver, ISO, and other styles
5

Bohman, Ljung Daniella, and Lina Ekeroth. "Using the Dual Control Model to explore female sexual function and dysfunction in a Swedish sample: A cross-sectional study." Thesis, Örebro universitet, Institutionen för juridik, psykologi och socialt arbete, 2014. http://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-38178.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Yuen, Hang-yuk. "A study of sexual dysfunction in female breast cancer patients /." Hong Kong : University of Hong Kong, 1996. http://sunzi.lib.hku.hk/hkuto/record.jsp?B19470794.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Yuen, Hang-yuk, and 袁亨玉. "A study of sexual dysfunction in female breast cancer patients." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 1996. http://hub.hku.hk/bib/B31250336.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Beharry, Rochard Kelshall Sheldon. "Development and characterization of a rat model of female sexual dysfunction." Thesis, National Library of Canada = Bibliothèque nationale du Canada, 2001. http://www.collectionscanada.ca/obj/s4/f2/dsk3/ftp05/MQ63269.pdf.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Smith, Ellen Kaye. "An Examination of the Relationship between Authenticity and Female Sexual Dysfunction." ScholarWorks, 2016. https://scholarworks.waldenu.edu/dissertations/2059.

Full text
Abstract:
Since the late 1990s, researchers have reported a high degree of sexual dysfunction among American women that is associated with significant negative consequences (e.g., reduced quality of life and sexual satisfaction). In addition, sexual satisfaction is a primary factor in marital stability. Because of the widespread impact on both individual well-being and marital relationships, female sexual dysfunction is a significant public health problem. Most research has supported the predominance of psychocultural factors in women's sexual issues. Authenticity, defined by Kernis and Goldman as acting in accord with one's natural inclinations, is associated with increased well-being, but researchers have often overlooked it in the literature on female sexual dysfunction. This study, guided by Kernis and Goldman's authenticity theory, argued that gender culture impairs the ability of women to be authentic in the sexual realm, and, thereby, increases the risk of sexual problems. The purpose of this research study was to examine the relationship between authenticity, as measured by The Authenticity Inventory, Version 3, and female sexual dysfunction, as measured by The Female Sexual Function Index and The Female Sexual Distress Scale, Revised, in a group of 55 women attending an online university. The hypothesis was that women with higher rates of dysfunction and/or distress would score lower on authenticity. The results from a regression analysis did not reach significance and failed to confirm the hypothesis; however, there was an association between distress and dysfunction. This study contributes to social change by examining an association between authenticity and female sexual dysfunction that is of help to researchers and therapists working with women in the area of sexual health.
APA, Harvard, Vancouver, ISO, and other styles
10

Dundon, Carolyn Marie. "The Cortisol/DHEA Ratio and Sexual Function in Women with and without a History of Depression." ScholarWorks @ UVM, 2014. http://scholarworks.uvm.edu/graddis/498.

Full text
Abstract:
The comorbidity between female sexual dysfunction (FSD) and major depressive disorder (MDD) is well documented; however, the mechanism(s) underlying the relationship between these disorders has not been defined. The literature has associated the adrenal hormones cortisol and dehydroepiandrosterone (DHEA) with FSD and MDD, suggesting a biological mechanism that may elucidate the comorbidity between these disorders. Based on evidence pointing to a high cortisol/DHEA ratio (C/D Ratio) in MDD and low DHEA in FSD, this study investigated if the potential association between a high C/D Ratio and FSD would be greater for women with a history of MDD when compared to women without a history of MDD. Two groups of women (MDD history group; control group), each with a range of sexual function, collected saliva samples, completed questionnaires, and participated in a clinical interview and a psychophysiological assessment. Results did not support the hypothesis that the relationship between the C/D Ratio and sexual function would be greater for women with a history of MDD. Relevant to the effects of hormones on sexual function, a higher C/D Ratio was associated with lower frequency of sexual activity and lower sexual assertiveness. Results also showed DHEA positively associated with overall frequency of sexual activity, while cortisol was associated with lower subjective assessment of sexual desire/arousal prior to erotic stimuli. Lastly, secondary analyses revealed a positive association between DHEA and frequency of sexual activity, which was mediated by women's sexual desire. These results suggest that the effects of the C/D Ratio on FSD are not associated with a history of MDD. Results also point to contrasting roles for C/D Ratio and DHEA in FSD. In particular, a high C/D Ratio may have inhibitory effects on frequency of sexual activity and sexual assertiveness, while high DHEA may have facilitatory effects on sexual activity frequency through heightened sexual desire. Lastly, high cortisol may predispose women to have a negative assessment of sexual stimuli. These findings contribute to a further understanding of the roles of the C/D Ratio, DHEA, and cortisol in female sexuality and offer support for future studies investigating the role of these hormones in FSD.
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Female sexual dysfunctions"

1

Costantini, Elisabetta, Donata Villari, and Maria Teresa Filocamo, eds. Female Sexual Function and Dysfunction. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-41716-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Sexual dysfunction: Female and male perspectives. Hauppauge, N.Y: Nova Science Publishers, 2011.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Goldstein, Irwin, Anita H. Clayton, Andrew T. Goldstein, Noel N. Kim, and Sheryl A. Kingsberg, eds. Textbook of Female Sexual Function and Dysfunction. Chichester, UK: John Wiley & Sons, Ltd, 2018. http://dx.doi.org/10.1002/9781119266136.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Dx/Rx: Sexual dysfunction. Sudbury, Mass: Jones & Bartlett Learning, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Zaslau, Stanley. Dx/Rx: Sexual dysfunction. Sudbury, Mass: Jones & Bartlett Learning, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Patel, Reena. Exploring female sexual dysfunction to improve the delivery of sexual health care. Leicester: De Montfort University, 2004.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Gibbes, J. Discoursing desire: A discourse analytic study of female sexual dysfunction. London: UEL, 1994.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Zaslau, Stanley. Dx/Rx: Sexual dysfunction in men and women. Sudbury, Mass: Jones & Bartlett Learning, 2011.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Zaslau, Stanley. Dx/Rx: Sexual dysfunction in men and women. Sudbury, Mass: Jones & Bartlett Learning, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Zaslau, Stanley. Dx/Rx: Sexual dysfunction in men and women. Sudbury, Mass: Jones & Bartlett Learning, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Female sexual dysfunctions"

1

Bitzer, Johannes, and Paraskevi-Sofia (Evie) Kirana. "Female Sexual Dysfunctions." In Psychiatry and Sexual Medicine, 109–34. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-52298-8_10.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Lakshmi, Manu, and Shah Dupesh Khan. "Female Sexual Dysfunction." In Sexual Medicine, 57–65. Singapore: Springer Singapore, 2018. http://dx.doi.org/10.1007/978-981-13-1226-7_6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Levy, Barbara. "Female Sexual Dysfunction." In Ambulatory Gynecology, 309–17. New York, NY: Springer New York, 2018. http://dx.doi.org/10.1007/978-1-4939-7641-6_20.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Kammerer-Doak, Dorothy, and Rebecca Rogers. "Female Sexual Dysfunction." In Pelvic Floor Disorders, 909–21. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-40862-6_74.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Shabsigh, Ridwan, Anne R. Davis, Aristotelis G. Anastasiadis, Nawras Makhsida, and Grace Yan. "Female Sexual Dysfunction." In Oral Pharmacotherapy for Male Sexual Dysfunction, 423–43. Totowa, NJ: Humana Press, 2005. http://dx.doi.org/10.1385/1-59259-871-4:423.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Salonia, Andrea, Giulia Castagna, and Francesco Montorsi. "Female Sexual Dysfunction (FSD)." In Clinical Uro-Andrology, 147–68. Berlin, Heidelberg: Springer Berlin Heidelberg, 2014. http://dx.doi.org/10.1007/978-3-662-45018-5_9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Giraldi, Annamaria. "Classifying Female Sexual Dysfunction." In Cancer and Sexual Health, 93–103. Totowa, NJ: Humana Press, 2011. http://dx.doi.org/10.1007/978-1-60761-916-1_8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Rashid, Tina G., Phillip Thomas, and James Bellringer. "Assessment and management of the male to female transgender patient." In Male Sexual Dysfunction, 314–22. Chichester, UK: John Wiley & Sons, Ltd, 2016. http://dx.doi.org/10.1002/9781118746509.ch33.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Bertozzi, Maria Antonella, and Valeria Ales. "Female Sexual Function During Male Sexual Dysfunction and Vice Versa." In Female Sexual Function and Dysfunction, 145–56. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-41716-5_13.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Srikrishna, Sushma, and Linda Cardozo. "Female Genital Cosmetic Surgery." In Female Sexual Function and Dysfunction, 175–88. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-41716-5_16.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Female sexual dysfunctions"

1

Hermankova, B., M. Spiritovic, H. Smucrova, S. Oreska, H. Storkanova, K. Pavelka, J. Vencovsky, L. Senolt, R. Becvar, and M. Tomcik. "SAT0483 Female sexual dysfunction in patients with systemic sclerosis." In Annual European Congress of Rheumatology, EULAR 2018, Amsterdam, 13–16 June 2018. BMJ Publishing Group Ltd and European League Against Rheumatism, 2018. http://dx.doi.org/10.1136/annrheumdis-2018-eular.7454.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Hermankova, B., M. Spiritovic, H. Smucrova, S. Oreska, H. Storkanova, K. Pavelka, L. Senolt, H. Mann, J. Vencovsky, and M. Tomcik. "THU0399 Female sexual dysfunction in patients with idiopathic inflammatory myopathies." In Annual European Congress of Rheumatology, EULAR 2018, Amsterdam, 13–16 June 2018. BMJ Publishing Group Ltd and European League Against Rheumatism, 2018. http://dx.doi.org/10.1136/annrheumdis-2018-eular.7551.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Stoian, Dana, Liana PAter, Flavius Pater, and Mihaela Craciunescu. "Female sexual dysfunction in young adult women - Impact of age and lifestyle." In 10TH INTERNATIONAL CONFERENCE ON MATHEMATICAL PROBLEMS IN ENGINEERING, AEROSPACE AND SCIENCES: ICNPAA 2014. AIP Publishing LLC, 2014. http://dx.doi.org/10.1063/1.4907303.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

PIOLA, BRUNA FERRAZ GUTIERREZ, FLÁVIA JATOBÁ BARROS, JOSÉ ANCHIETA BRITO, and LAURINDO FERREIRA ROCHA JR. "SEXUAL DYSFUNCTION IN FEMALE PACIENTS WITH SYSTEMIC LUPUS ERYTEMATHOSUS AND CORRELATIONS WITH CLINICAL PARAMETERS." In 36º Congresso Brasileiro de Reumatologia. São Paulo: Editora Blucher, 2019. http://dx.doi.org/10.5151/sbr2019-584.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Wheldon, Christopher W., Megan C. Roberts, Michelle I. Silver, and Ulrike Boehmer. "Abstract A62: Differences in sexual dysfunction between lesbian, bisexual, and heterosexual female breast cancer survivors." In Abstracts: Tenth AACR Conference on The Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; September 25-28, 2017; Atlanta, GA. American Association for Cancer Research, 2018. http://dx.doi.org/10.1158/1538-7755.disp17-a62.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Chanda, Arnab, Vinu Unnikrishnan, Holly E. Richter, and Mark E. Lockhart. "Computational Modeling of Anterior and Posterior Pelvic Organ Prolapse (POP)." In ASME 2016 International Mechanical Engineering Congress and Exposition. American Society of Mechanical Engineers, 2016. http://dx.doi.org/10.1115/imece2016-67949.

Full text
Abstract:
Pelvic Organ Prolapse (POP) is a condition of the female pelvic system suffered by a significant proportion of women in the U.S. and more across the globe, every year. POP is caused by the weakening of the pelvic floor muscles and musculo-connective tissues due to child birth, menopause and morbid obesity. Prolapse of the pelvic organs namely the urinary bladder, uterus, and rectum into the vaginal canal can cause vaginal discomfort, strained urination or defecation, and sexual dysfunction. To date, success rates of native tissue POP surgeries vary from 50–70% depending on the definition of cure and time-point of assessment. A better understanding of the mechanics of prolapse may lead to improvement in surgical outcomes. In the current work, the mechanics of progression of anterior and posterior vaginal prolapse were modeled to understand the effect of bladder fill and posterior vaginal stresses using computational approaches. A realistic and full-scale female pelvic system model, comprised of the urinary bladder, vaginal canal, uterus, rectum, and fascial connective tissue, was developed using image segmentation methods. All of the relevant loads and boundary conditions were applied based on a comprehensive study of the anatomy and functional morphology of the female pelvis. Hyperelastic material models were adopted to characterize all pelvic tissues, and a non-linear analysis was invoked. In the first set of simulations, a realistic bladder filling and vaginal tissue stiffening in prolapse were modeled and their effects on the anterior vaginal wall (AVW) were estimated in terms of the induced stresses, strains and displacements. The degree of bladder filling was found to be a strong indicator of stress build-up on the AVW. Also, vaginal tissue stiffening was found to increase the size of the high stress zone on the AVW. The second simulation consisted of modeling the different degrees of posterior vaginal wall (PVW) prolapse, in the presence of an average abdominal pressure. The vaginal length was segmented into four sections to study the localized stresses and strains. Also, a clinically well-known phenomena known as the kneeling effect was observed with the PVW in which the vaginal wall displaces away from the rectum and downward towards the vaginal hiatus. All of these results have relevant clinical implications and may provide important perspective for better understanding the mechanics of POP pathophysiology.
APA, Harvard, Vancouver, ISO, and other styles
7

Sadeghi Bahmani, D., V. Farnia, M. Alikhani, F. Tatari, E. Holsboer-Trachsler, and S. Brand. "Rosa Damascena Oil improved methadone-induced sexual dysfunction and happiness in female patients with opium use disorder under methadone maintenance therapy – results from a double-blind, randomized, and placebo-controlled trial." In Abstracts of the 30th Symposium of the AGNP. Georg Thieme Verlag KG, 2017. http://dx.doi.org/10.1055/s-0037-1606431.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Female sexual dysfunctions' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography